Apheresis in Treatment of the Inflammatory Demyelinating Peripheral Neuropathies
- 1 February 2002
- journal article
- review article
- Published by Wiley in Therapeutic Apheresis
- Vol. 6 (1) , 53-56
- https://doi.org/10.1046/j.1526-0968.2002.00401.x
Abstract
The inflammatory demyelinating peripheral neuropathies are recognizable treatable entities within the broad field of diseases of the peripheral nervous system. Most peripheral nerve diseases are still of undetermined causation and have no direct disease‐modifying treatment. This paper reviews the diagnostic features of the inflammatory neuropathies, presumed mechanisms of pathogenesis, and the role of apheresis, along with other immunomodulating therapies, in the management of these diseases.Keywords
This publication has 12 references indexed in Scilit:
- Mechanisms of Immune Regulation in the Peripheral Nervous SystemBrain Pathology, 1999
- Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyneuropathySeminars in Neurology, 1998
- Appropriate number of plasma exchanges in Guillain‐Barré syndromeAnnals of Neurology, 1997
- Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndromeThe Lancet, 1997
- Immunopathogenesis and treatment of the guillain‐barré syndrome—part IMuscle & Nerve, 1995
- A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 1994
- Limited Relapse in Guillain-Barre Syndrome After Plasma ExchangeArchives of Neurology, 1988
- Efficiency of plasma exchange in Guillain‐Barré syndrome: Role of replacement fluidsAnnals of Neurology, 1987
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyNew England Journal of Medicine, 1986
- Plasmapheresis and acute Guillain‐Barre syndromeNeurology, 1985